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Condensation:
There is large variations in outcomes reporting in clinical studies on pregnant women with 
epilepsy; there is need to identify a set of core outcome to harmonise reporting in future 
clinical studies.
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Abstract:
Studies on pregnant women with epilepsy should evaluate both neurological and pregnancy 
outcomes. We undertook a systematic review of the literature of studies on pregnant women 
with epilepsy to collate the outcomes reported, and the quality of outcomes report in these 
studies.
We searched major electronic databases (from 1999 until January 2015). Two independent 
reviewers selected studies and extracted data on study design, the risk of bias of the studies, 
journal impact factor and the quality of reported outcomes. We assessed the quality outcomes 
report using a six items standardised tool (score range 0-6).
There were 70 different outcomes reported in 232 studies (maternal neurological (13/70, 
19%), fetal and neonatal (28/70, 40%), and obstetric outcomes (29/70, 41%)). Most studies 
reported on major congenital fetal abnormalities (103/232, 44%), followed by live birth 
(60/232, 26%). Quality of the reported outcomes was poor (mean 1·54, SD 1·36). It was 
associated with journal impact factor (p=0·007), but not with study design (p=0·60), or risk 
of bias (p=0·17).
The outcomes reported in studies on pregnant women with epilepsy varied widely, and the
quality of the outcomes report was poor. There is a need to identify a set of core outcome to 
harmonise reporting in future clinical studies.
Key words: Epilepsy, pregnancy, maternal, fetal, neurological, outcomes.
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Introduction
Epilepsy in pregnancy is one of the major contributory factors to maternal morbidity and
mortality.(1,2) About a third of women with epilepsy experience seizure deterioration in 
pregnancy. (3) Often they are exposed to anti-epileptic drugs (AED) before and during 
pregnancy. Both uncontrolled seizures, and exposure to AEDs contribute to maternal 
complications (4), and adverse offspring outcomes. (5)
Existing studies on epilepsy in pregnancy tend to focus on evaluation of fetal and 
childhood outcomes related to AED exposure.(6) The proportion of studies that report on 
important and clinically relevant outcome such as seizure control in pregnancy, and 
obstetric complications is not known. Given the relative rarity of epilepsy as a pre-existing 
medical condition in pregnancy, we can ill afford heterogeneity in reported outcomes. 
Standardised and consistent reporting leads to meaningful evidence synthesis. Identifying 
gaps in outcome reporting is crucial to adequately plan future studies.
Before standardising core outcome sets for studies on pregnant women with epilepsy, 
there is a need to map the various outcomes reported in primary studies. We undertook a 
systematic review to assess the range and the quality of the outcomes reported in clinical 
studies on pregnant women with epilepsy.
Material and methods:
We undertook a systematic review in line with current recommendations using a prospective 
protocol (7), and reported to comply with PRISMA guidelines (Appendix 1).
Literature search:
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We searched major electronic databases MEDLINE, Embase, CINAHL, AMED and 
Cochrane Library (1999-January 2015) for studies on women with epilepsy. We combined 
the Mesh terms for ''pregnancy'', ''anti-epileptic drugs'', and ''epilepsy'' using the Boolean 
operators AND or OR as appropriate (Appendix 2). There were no language restrictions. We 
manually searched the bibliographies of relevant articles to identify papers that were not 
captured by electronic searches. We contacted the authors for additional data where required.
Study selection:
Two independent reviewers (BHA and JT) selected the studies. We screened the abstracts and 
obtained the full copies of all relevant articles. Then, we evaluated the retrieved manuscripts 
in detail to identify studies that may be eligible for inclusion. Any discrepancies were 
resolved by discussion with a third reviewer (ST). We excluded studies on non-pregnant 
population, only on pharmacodynamics of AEDs, surveys, case series, case reports, and 
animal studies.
Quality assessment of the included studies:
Two independent reviewers (BHA and JT) assessed the risk of bias in the included studies
using the Newcastle-Ottawa Scale (8) for study selection, comparability and outcome 
assessment. The studies were allocated stars according to the rating. A study was awarded a 
maximum of four stars for selection, two for comparability, and three for ascertainment of 
exposure. Studies were considered to have a low risk of bias if they scored 4 stars for 
selection, 2 stars for comparability, and 3 stars for assessment of outcomes (8). Studies with 
only 1 or no stars for selection, comparability, or outcome assessment were considered to 
have high risk of bias. The risk of bias was considered to be medium in studies with 2 or 3 
stars for selection, 2 or 1 for comparability, and 2 stars for outcome assessment. For 
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randomised studies we planned to assess the risk of bias using the Cochrane risk of bias 
assessment tool.(9)
Quality assessment of reported outcomes:
We assessed the quality of the outcomes reported using a standardised six items tool.(10) One 
point was awarded if each of the following items were met: primary outcome stated; clearly 
defined primary outcome; authors stated whether there were any secondary outcomes; clearly 
defined secondary outcomes; authors stated the rationale for choosing the reported outcomes; 
methods were used to enhance the quality of outcomes measurement such as the repeating 
measures or training in the use of measurement tools. A maximum score of 6 could be 
awarded for a study. We considered a score above 4 to be of high quality, 2 to 4 as moderate 
quality, and less than 2 as low quality. 
Data extraction and analysis:
Two independent reviewers (BHA, JT) extracted data on study design (cohort studies, case 
control studies, and randomised controlled trials), the outcomes reported, country of the 
study, type of journal (general vs. specialist), impact factor of the journal, and year of 
publication using pre-designed forms. Journals with an impact factor above the 95th 
percentile of all included studies were considered to have high impact. 
We categorised the reported outcomes into three main domains: Maternal neurological, 
obstetric, and fetal and neonatal outcomes. We grouped similar outcomes together, and
estimated the proportion of these grouped outcomes that were reported in each domain. In the 
maternal neurological domain, outcomes related to AED such frequency of AED use in 
pregnancy, AED serum levels, and AED maternal toxicity were categorised as AED related 
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outcomes; and postnatal depression and psychosis were grouped as mental health related 
outcomes. In the fetal and neonatal domain, outcomes such as birth weight, neonatal height, 
and head circumference were categorised as anthropometric outcomes; and neonatal 
conditions such as acute respiratory distress syndrome, hypotonia, feeding problems, and 
hypoglycemia as neonatal clinical complications. In the obstetric domain, pregnancy viability 
outcomes included live birth, miscarriage, ectopic pregnancy, and termination; pregnancy 
specific complications included pre eclampsia and gestational diabetes; and placenta praevia 
and accreta were grouped as placental abnormalities. 
We estimated the rates of reporting for various outcome categories in each domain, and also 
for individual outcomes. Due to the variation in reported outcomes, we refrained from 
summarising the overall rates. We used the Mann-Whitney test to determine the significance 
of comparative statistics for non-parametric data. Multiple linear regression analysis was 
done to assess the association between the quality of outcomes’ report and the journal impact 
factor, and the risk of bias. We did not assess publication bias, as it was not appropriate. All 
analyses were undertaken in Microsoft Excel and SPSS (Version 20.0. Armonk, NY: IBM 
Corp).
Results
From 482 potentially relevant citations, we included 232 studies in our review, Figure (1), 
Appendix (3). Nine studies were excluded due to inappropriate study design (2 focus groups, 
6 surveys, 1 case report) and 241 studies did not report primary data in a pregnant population. 
Study characteristics and risk of bias:
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All the included studies were observational in design. Over 80% were cohort studies 
(218/232, 94%), of which 171(78%) were prospective and 47 (22%) were retrospective 
cohorts. Only six per cent (14/232) were case-control studies. The majority of the studies 
were conducted in mainland Europe (120/232, 52%) followed by the USA (41/232, 18%) and 
the UK (35/232, 15%). Countries from Asia (31/232, 13%) and South America (8/232, 3%) 
published the least number of studies in this field. Nine tenth of all studies (209/232, 90%) 
were published in specialist journals, and only a tenth (23/232, 10%) were published in 
general medical journals. Less than 5% of studies (11/232) were published in journals with 
high impact factor.
The mean star rating for the risk of bias assessment using the Newcastle-Ottawa Scale was 
4·7 (SD 2·0) out of a maximum of nine stars. Over half of the included studies had a medium 
risk of selection bias (131/232, 56%) and a quarter had low risk of selection bias (61/232, 
26%) (Figure 2). The risk of comparability bias was high in half of the studies (117/232, 
50%) and medium in a third (75/232, 32%) of studies. More than half of the included studies 
had high risk of outcome assessment bias (130/232, 56%), and a quarter had a medium risk 
(52/232, 22%). 
Variation in the reported outcomes:
Overall, 70 different individual outcomes were reported in 232 clinical studies on pregnant 
women with epilepsy (Figure 3, Table 1). The studies reported 13 different categories of 
maternal neurological, 29 obstetric, and 28 fetal and neonatal outcomes. AED related 
outcomes (70/232, 30%) were the most commonly reported from maternal neurological
domain, followed by seizure control in 24% of studies (55/232). About 80% of all studies 
reported on congenital abnormality in the baby (189/232), followed by newborn 
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anthropometric outcomes (102/232, 44%). Outcomes related to viability of pregnancy
(137/232, 59%) were frequently reported from the obstetric domains. 
Seizure control in pregnancy was the most commonly reported individual neurological 
outcome (56/232, 24%), followed by the rate of AED use (53/232, 23%). All other 
neurological outcomes were reported in less of 5% of all included studies. A quarter of 
studies reported live birth rates (60/232, 26%), the most commonly reported obstetric 
outcome, followed by pre term birth (42/232, 18%). Mode of delivery, miscarriage and 
termination of pregnancy were reported in about 15%, and other obstetric outcomes were 
reported in less than 10% of all studies. In the newborn, major and minor congenital 
abnormalities were the most commonly reported individual outcomes in 44% (103/232) and 
36% (86/232) of studies. A fifth of studies evaluated birth weight (46/232), stillbirth (41/232) 
and neurodevelopment of the offspring (49/232), and 13% reported on intra uterine growth 
restriction (31/232). Neonatal mortality and admission to NICU (neonatal intensive care unit) 
were reported in less than 5% of the all studies.
Quality of the reported outcomes:
The mean quality of the reported outcomes across all studies was 1.5 (SD 1·4). Primary 
outcomes were not stated in two third (148/232, 64%) of the studies, and not clearly defined 
in three quarter (171/232, 74%) of them (Figure 4). Secondary outcomes were not stated in 
over 95% of the studies (222/232, 96%) and clear definitions of secondary outcomes were 
absent in 97% of them (225/232).The authors did not explain the use of the reported 
outcomes in three quarter (171/232, 74%) of the studies and no methods were used to 
enhance the quality of measuring outcomes in 41% (96/232). 
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There were no differences in the mean scores for outcome reporting quality for cohort and 
case control studies (p=0·60), and for prospective and retrospective cohort studies (p=0·24).
Multiple linear regression analysis showed a significant association between the outcome 
reporting quality and the impact factor of the journal (β= 0.037, SE= 0.014, p= 0.007). There 
was no association between the quality of the studies and the outcome reporting quality (β= -
0.059, SE= 0.043, p= 0.17). 
Comments:
Studies on pregnant women with epilepsy have not employed randomisation, have a high risk 
of bias, and vary widely in the reporting of outcomes. They focus on fetal and neonatal 
outcomes, particularly on congenital abnormalities and viability of pregnancy, with less focus 
on other clinical outcomes. 
Our review is the first to look at the outcomes reported in clinical studies on pregnant women 
with epilepsy. We used a structured comprehensive search strategy with no language 
restrictions. Although we aimed to capture all relevant outcomes, it is possible that studies in 
non-Medline indexed journals may have not been captured. We assessed the methodological 
quality of all included studi s, and used a well-defined standardised tool to evaluate the 
quality of the outcomes reported (10). We categorised outcomes into three relevant domains 
and estimated the frequency of grouped and individual outcomes. 
Assessment of risk related to congenital abnormalities appears to be the main focus in most 
studies. Given the significance of this finding, relative ease of obtaining relevant data, and 
growing evidence on association of AED and epilepsy, and congenital abnormalities, most 
studies have reported this finding. National and international registries appear to be the main 
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source for these outcomes. Anthropometric outcomes such as the birth weight of the newborn 
have also been widely reported, possibly due to the easy availability of such data. Despite 
uncontrolled seizures being the main contributor of maternal deaths in women with epilepsy, 
seizure related outcomes were evaluated in less than half of the studies. Furthermore, there is 
wide variation in the measurement of seizure deterioration in pregnancy, with no validated 
tool for use in pregnancy. Very few studies assessed or reported obstetric outcomes such as 
pre term birth, pregnancy related complications, and mode of delivery. Although women with 
epilepsy, particularly those on AED, are at increased risk of depression, mental health related 
outcomes were not the main focus in most studies.
Most of the outcomes reported appeared to be driven by clinicians, and very few were patient 
oriented, such as quality of life. Few studies evaluated the effect of epilepsy and AED 
exposure on symptoms and functional ability of the mother in pregnancy and afterwards. 
Involvement of patients in the study design may have resulted in the inclusion of above 
outcomes in studies. The input from research groups that are founded to collect evidence on 
Patient-Reported Outcome Measures (PROMs) and Patient Reported Experience Measures 
(PREMs) (11) may improve the current situation.
Identifying a set of core outcomes for assessment in studies on pregnant women with epilepsy
will allow studies to focus on those outcomes that are considered to be clinically relevant to 
both healthcare professionals and patients. Furthermore, it will facilitate robust evidence 
synthesis for key outcomes. Any effort to generate a set of core outcomes for clinical trials on 
pregnant women with epilepsy requires a consensus between different stakeholders involved 
in the management of epilepsy in pregnancy such as obstetricians, specialist midwives, 
neurologists, epilepsy nurses, neonatologists, and patient representatives. This will provide 
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guidance for future researchers to evaluate outcomes that are relevant to clinical practice, but 
less reported in the literature. Internationally the COMET (12) and The CROWN (13)
initiatives have reemphasised the importance of developing core outcome sets for clinical 
studies. Such endeavour requires active engagement between healthcare professionals, 
researchers, policy makers, and patients using a robust consensus methodology. (13)
Our work has highlighted the wide variation in outcomes that are currently reported, and their 
poor quality in clinical studies on pregnant women with epilepsy. Development of a core 
outcome set to be minimally reported will address the current deficiencies. 
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Condensation:
There is large variations in outcomes reporting in clinical studies on pregnant women with 
epilepsy; there is need to identify a set of core outcome to harmonise reporting in future 
clinical studies.
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Table (1): Frequency of reported individual maternal neurological, obstetric, fetal 
and neonatal outcomes in 232 studies on pregnant women with epilepsy
1 AED related outcomes; 2Mental health; 3 Viability of pregnancy; 4Pregnancy related clinical complications; 
5Placental abnormalities; 6Pre term birth; 7Amniotic fluid abnormalities; 8Congenital abnormalities; 
9Anthropometric outcomes; 10Perinatal mortality; 11Neonatal clinical complications; 12Autism spectrum 
disorder
Maternal neurological 
outcomes
No. of 
studies 
(n)
% 
(n/N)
Obstetric 
outcomes
No. of 
studies 
(n)
% 
(n/N)
Fetal and neonatal 
outcomes
No. of 
studies 
(n)
% 
(n/N)
Seizure control in 
pregnancy
56 24.1% Live birth3 60 25.9% Major congenital 
abnormalities8
103 44.4%
AED use in pregnancy1 53 22.8% Preterm birth6 42 18.1% Minor congenital 
abnormalities8
86 36.6%
AED serum levels1 7 3.0% Miscarriage3 39 16.8% Neurodevelopment of 
offspring
49 21.1%
Folic acid intake in 
pregnancy
6 2.6% Termination of 
pregnancy3
36 15.5% Birth weight9 46 19.8%
Postnatal depression2 6 2.6% Mode of delivery 35 15.1% Stillbirth10 44 19.0%
AED compliance in 
pregnancy1
5 2.2% Pre-eclampsia4 18 7.8% Intra-uterine growth 
restriction9
31 13.4%
AED maternal toxicity1 4 1.7% Pregnancy induced 
hypertension4
13 5.6% Apgar scores 25 10.8%
Anxiety2 2 0.9% Vaginal bleeding4 10 4.3% Neonatal head 
circumference9
12 5.2%
Eating disorders2 1 0.4% Induction of labour 9 3.9% Neonatal height9 12 5.2%
Fear of Child birth2 1 0.4% Postpartum 
haemorrhage4
9 3.9% Admission to neonatal 
intensive care unit
9 3.9%
Quality of life 1 0.4% Placental abruption5 7 3.0% Fetal distress 8 3.4%
Sudden unexpected 
death in epilepsy
1 0.4% Placenta previa5 7 3.0% Neonatal death10 7 3.0%
Postpartum psychosis2 1 0.4% Gestational 
diabetes4
6 2.6% Neonatal haemorrhagic 
disease11
7 3.0%
Premature rupture 
of membrane6
6 2.6% Neonatal withdrawal 
syndrome11
6 2.6%
Hyperemesis 
gravidarium4
3 1.3% Acute respiratory distress 
syndrome in neonates11
4 1.7%
Breech presentation 3 1.3% Neonatal anaemia11 4 1.7%
Eclampsia4 3 1.3% Autism spectrum disorder12 3 1.3%
Polyhydramnios7 3 1.3% Neonatal 
icterus/convulsions11
2 0.9%
Urinary tract 
infection4
3 1.3% Attention deficit 
hyperactivity disorder12
1 0.4%
Ectopic pregnancy3 2 0.9% Fetal anti convulsant 
syndrome
1 0.4%
Blood transfusion 2 0.9% AED cord levels 1 0.4%
Oligohydramnios7 2 0.9% Cephalheamatoma11 1 0.4%
Perineal tears4 2 0.9% Feeding problems11 1 0.4%
Antepartum 
haemorrhage4
1 0.4% Neonatal hyperglycemia11 1 0.4%
Endometriosis in 
pregnancy
1 0.4% Neonatal hypoglycemia11 1 0.4%
Maternal mortality 1 0.4% Neonatal hypocalcemia11 1 0.4%
Placental retention5 1 0.4% Neonatal hypotonia11 1 0.4%
Prolonged labour 1 0.4% Sedation syndrome11 1 0.4%
Twin Pregnancy 1 0.4%
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Table (1): Frequency of reported individual maternal neurological, obstetric, fetal 
and neonatal outcomes in 232 studies on pregnant women with epilepsy 
 
1
 AED related outcomes; 
2
Mental health; 
3
 Viability of pregnancy; 
4
Pregnancy related clinical complications; 
5
Placental abnormalities; 
6
Pre term birth; 
7
Amniotic fluid abnormalities; 
8
Congenital abnormalities; 
9
Anthropometric outcomes; 
10
Perinatal mortality; 
11
Neonatal clinical complications; 
12
Autism spectrum 
disorder 
 
 
Maternal neurological 
outcomes 
No. of 
studies 
(n) 
 
% 
(n/N) 
Obstetric 
outcomes 
No. of 
studies 
(n) 
 
% 
(n/N) 
Fetal and neonatal 
outcomes 
No. of 
studies 
(n) 
 
% 
(n/N) 
Seizure control in 
pregnancy 
56 24.1% Live birth3 60 25.9% Major congenital 
abnormalities8 
103 44.4% 
AED use in pregnancy1 53 22.8% Preterm birth6 42 18.1% Minor congenital 
abnormalities8 
86 36.6% 
AED serum levels1 7 3.0% Miscarriage3 39 16.8% Neurodevelopment of 
offspring 
49 21.1% 
Folic acid intake in 
pregnancy 
6 2.6% Termination of 
pregnancy3 
36 15.5% Birth weight9 46 19.8% 
Postnatal depression2 6 2.6% Mode of delivery 35 15.1% Stillbirth10 44 19.0% 
AED compliance in 
pregnancy1 
5 2.2% Pre-eclampsia4 18 7.8% Intra-uterine growth 
restriction9 
31 13.4% 
AED maternal toxicity1 4 1.7% Pregnancy induced 
hypertension4 
13 5.6% Apgar scores 25 10.8% 
Anxiety2 2 0.9% Vaginal bleeding4 10 4.3% Neonatal head 
circumference9 
12 5.2% 
Eating disorders2 1 0.4% Induction of labour 9 3.9% Neonatal height9 12 5.2% 
Fear of Child birth2 1 0.4% Postpartum 
haemorrhage4 
9 3.9% Admission to neonatal 
intensive care unit 
9 3.9% 
Quality of life 1 0.4% Placental abruption5 7 3.0% Fetal distress 8 3.4% 
Sudden unexpected 
death in epilepsy 
1 0.4% Placenta previa5 7 3.0% Neonatal death10 7 3.0% 
Postpartum psychosis2 1 0.4% Gestational 
diabetes4 
6 2.6% Neonatal haemorrhagic 
disease11 
7 3.0% 
   Premature rupture 
of membrane6 
6 2.6% Neonatal withdrawal 
syndrome11 
6 2.6% 
   Hyperemesis 
gravidarium4 
3 1.3% Acute respiratory distress 
syndrome in neonates11 
4 1.7% 
   Breech presentation 3 1.3% Neonatal anaemia11 4 1.7% 
   Eclampsia4 3 1.3% Autism spectrum disorder12 3 1.3% 
   Polyhydramnios7 3 1.3% Neonatal 
icterus/convulsions11 
2 0.9% 
   Urinary tract 
infection4 
3 1.3% Attention deficit 
hyperactivity disorder12 
1 0.4% 
   Ectopic pregnancy3 2 0.9% Fetal anti convulsant 
syndrome 
1 0.4% 
   Blood transfusion 2 0.9% AED cord levels 1 0.4% 
   Oligohydramnios7 2 0.9% Cephalheamatoma11 1 0.4% 
   Perineal tears4 2 0.9% Feeding problems11 1 0.4% 
   Antepartum 
haemorrhage4 
1 0.4% Neonatal hyperglycemia11 1 0.4% 
   Endometriosis in 
pregnancy 
1 0.4% Neonatal hypoglycemia11 1 0.4% 
   Maternal mortality 1 0.4% Neonatal hypocalcemia11 1 0.4% 
   Placental retention5 1 0.4% Neonatal hypotonia11 1 0.4% 
   Prolonged labour 1 0.4% Sedation syndrome11 1 0.4% 
   Twin Pregnancy 1 0.4%    
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Figure (1): Study identification and selection process in the systematic review of 
variation in outcomes reported in studies on pregnant women with epilepsy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Citations identified from electronic 
databases 
(n= 4679) 
Full-text articles assessed for eligibility 
(n= 482) 
Studies excluded after screening 
titles and/ or abstracts  
(n= 4197) 
 
Studies that did not meet the 
inclusion criteria  
(n= 250) 
-No primary data in pregnant 
population (n= 241) 
-Focus groups (n=2) 
-Surveys (n=6), 
-Case report (n=1) 
 
Number of studies included  
(n= 232) 
Number of outcomes (n= 70) 
-Maternal neurological outcomes  (n=13) 
-Fetal and neonatal outcomes (n= 28) 
-Obstetric outcomes (n= 29) 
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Figure (2): Risk of bias in studies of pregnant women with epilepsy assessedusing the 
Newcastle-Ottawa Scale 
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Figure (3): Frequency of reported outcomes in studies of pregnant women with 
epilepsy 
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Figure (4): Quality of outcomes report in studies on pregnant women with epilepsy  
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